137 related articles for article (PubMed ID: 1350482)
1. Antihypertensive effect of carvedilol: a preliminary dose-response study.
Casadei B; Conway J; Coats AJ; Bird R
Clin Investig; 1992; 70 Suppl 1():S37-8. PubMed ID: 1350482
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic and metabolic effects of carvedilol: a meta-analysis approach.
Stienen U; Meyer-Sabellek W
Clin Investig; 1992; 70 Suppl 1():S65-72. PubMed ID: 1350487
[TBL] [Abstract][Full Text] [Related]
3. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
4. Controlled-release carvedilol in the treatment of essential hypertension.
Weber MA; Sica DA; Tarka EA; Iyengar M; Fleck R; Bakris GL
Am J Cardiol; 2006 Oct; 98(7A):32L-38L. PubMed ID: 17023230
[TBL] [Abstract][Full Text] [Related]
5. Comparison of antihypertensive efficacy of carvedilol and nebivolol in mild-to-moderate primary hypertension: a randomized trial.
Erdoğan O; Ertem B; Altun A
Anadolu Kardiyol Derg; 2011 Jun; 11(4):310-3. PubMed ID: 21543293
[TBL] [Abstract][Full Text] [Related]
6. Carvedilol and atenolol once daily in the treatment of hypertension.
Luurila OJ; Härkönen R; Hilden M; Icen R; Kohvakka A; Linna M; Sillanpää J; Vänskä O; Lukkala K
J Hypertens Suppl; 1989 Dec; 7(6):S264-5. PubMed ID: 2576666
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a once-daily formulation of carvedilol for the treatment of hypertension.
Weber MA; Bakris GL; Tarka EA; Iyengar M; Fleck R; Sica DA
J Clin Hypertens (Greenwich); 2006 Dec; 8(12):840-9. PubMed ID: 17170609
[TBL] [Abstract][Full Text] [Related]
8. The effect of low dose carvedilol on circadian variation of blood pressure in patients with essential hypertension.
Ogihara T; Ikeda M; Goto Y; Yoshinaga K; Kumahara Y; Iimura O; Ishii M; Murakami E; Takeda T; Kokubu T
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S108-12. PubMed ID: 2454355
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study.
Galzerano D; Tammaro P; del Viscovo L; Lama D; Galzerano A; Breglio R; Tuccillo B; Paolisso G; Capogrosso P
Am J Hypertens; 2005 Dec; 18(12 Pt 1):1563-9. PubMed ID: 16364826
[TBL] [Abstract][Full Text] [Related]
10. Effect of combining extended-release carvedilol and lisinopril in hypertension: results of the COSMOS study.
Bakris GL; Iyengar M; Lukas MA; Ordronneau P; Weber MA
J Clin Hypertens (Greenwich); 2010 Sep; 12(9):678-86. PubMed ID: 20883227
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.
Ollivier JP; Durier P; Bussiere JL; Gayet JL
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S164-6. PubMed ID: 1974509
[TBL] [Abstract][Full Text] [Related]
12. Alpha 1-blocking properties of carvedilol during acute and chronic administration.
Giannattasio C; Cattaneo BM; Seravalle G; Carugo S; Mangoni AA; Grassi G; Zanchetti A; Mancia G
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S18-22. PubMed ID: 1378144
[TBL] [Abstract][Full Text] [Related]
13. Effects of carvedilol on blood pressure in patients with mild to moderate hypertension. A dose response study.
McPhillips JJ; Schwemer GT; Scott DI; Zinny M; Patterson D
Drugs; 1988; 36 Suppl 6():82-91. PubMed ID: 2908306
[TBL] [Abstract][Full Text] [Related]
14. Can intravenous beta blockade predict long-term haemodynamic benefit in chronic congestive heart failure secondary to ischaemic heart disease? A comparison between intravenous and oral carvedilol.
DasGupta P; Lahiri A
Clin Investig; 1992; 70 Suppl 1():S98-104. PubMed ID: 1350492
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
Deetjen A; Heidland A; Pangerl A; Meyer-Sabellek W; Schaefer RM
Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the hemodynamic effects of metoprolol and carvedilol in hypertensive patients.
Weber K; Bohmeke T; van der Does R; Taylor SH
Cardiovasc Drugs Ther; 1996 May; 10(2):113-7. PubMed ID: 8842502
[TBL] [Abstract][Full Text] [Related]
17. Daytime-selective antihypertensive activity of celiprolol.
Cleophas TJ; van der Meulen J; van de Luit L; Zwinderman AH
Angiology; 1999 Oct; 50(10):797-803. PubMed ID: 10535718
[TBL] [Abstract][Full Text] [Related]
18. Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosis.
Forrest EH; Bouchier IA; Hayes PC
J Hepatol; 1996 Dec; 25(6):909-15. PubMed ID: 9007720
[TBL] [Abstract][Full Text] [Related]
19. Response rate with respect to the blood pressure-lowering effect of the vasodilating and beta-blocking agent carvedilol.
Rittinghausen R
Drugs; 1988; 36 Suppl 6():92-101. PubMed ID: 2908307
[TBL] [Abstract][Full Text] [Related]
20. Effect of long-term carvedilol therapy on renal function in essential hypertension.
Tomita K; Marumo F
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S97-101. PubMed ID: 1378158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
